HomePortfoliosUdate for Sharpe

Udate for Sharpe

None Rebalancing
EUR
Moderate Risk
1.2yr backtest

Performance Summary

Total Return+23.76%
Annualized Return+19.22%
Volatility+14.10%
Sharpe Ratio1.22
Max Drawdown+15.64%

Holdings

Asset Allocation

Asset Class

Equity 100.0%
Holdings Details
Diversified global equity ETF portfolio targeting growth across US tech, European healthcare, emerging markets, and specialized sectors.
AssetTypeAllocationTER
DCAM.PA
Amundi PEA Monde (MSCI World) UCITS ETF AccFR001400U5Q4
ETF
40.0%0.2%
LYHLT.SW
Amundi STOXX Europe 600 Healthcare UCITS ETF AccLU1834986900
ETF
30.0%0.3%
PANX.PA
Amundi PEA US Tech Screened UCITS ETF AccFR0013412269
ETF
13.0%0.3%
MMS.PA
Lyxor MSCI EMU Small Cap UCITS ETF EURFR0010168773
ETF
5.0%0.4%
PAEEM.PA
Amundi PEA Emergent (MSCI Emerging) ESG Transition UCITS ETF AccFR0013412020
ETF
3.0%0.3%
LGWS.XETRA
Amundi MSCI EMU Value Factor UCITS ETF DistLU1598690169
ETF
3.0%0.4%
PINR.PA
Amundi PEA Inde (MSCI India) UCITS ETF AccFR0011869320
ETF
3.0%0.85%
SELD.XETRA
Amundi Stoxx Europe Select Dividend 30 UCITS ETF DistLU1812092168
ETF
3.0%0.3%
Total100.0%0.28%

Performance

Portfolio Value Over Time
Starting with 10,000 investment → now worth €12,376.11
Histogram of Monthly Returns
The portfolio had a positive return during 11 of the 15 months (73%)
Monthly Returns Heatmap
Best month: +6.7% • Worst month: -5.8% • Best year: 2025 (+13.9%) • Worst year: 2026 (+8.6%)
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2026+1.3%+1.4%-5.8%+6.7%+5.3%-------+8.6%
2025---0.1%-3.4%+4.8%-0.0%+3.1%+0.8%+1.6%+5.0%+1.0%+0.6%+13.9%
> +2%
0% to +2%
-2% to 0%
< -2%
Drawdown Analysis
Maximum drawdown: +15.64% • The longest drawdown period lasted for 4 months and was between March 2025 and July 2025. It reached a trough of -15.6%.

Dividend Income

Summary
This portfolio contains 3 distributing ETFs (11.0% of total allocation)

Total Dividends Received

49.01

3 payments

Dividend Yield

0.37%

(annualized)

Avg Per Payment

16.34

per event

All dividends are automatically reinvested at the payment date. The portfolio value shown includes the compounding effect of dividend reinvestment.

Annual Breakdown
Dividend income per calendar year
YearDividends
202549.02
Total49.01

Detailed Metrics

Returns
Total Return
+23.76%
Annualized Return
+19.22%
Avg Monthly Return
+1.48%
Risk
Volatility (Annual)
+14.10%
Max Drawdown
+15.64%
Positive Months
73%
Average Drawdown
-2.3%
Risk-Adjusted
Sharpe Ratio
1.22
Risk-free rate: 2.0%
Sortino Ratio
1.15
Downside risk adjusted
Return/Volatility
1.36
Calmar Ratio
1.23
Return/Max Drawdown
Ulcer Index
3.23
Drawdown depth & duration
Martin Ratio
0.05
Return/Ulcer Index
Backtest Configuration
Initial Investment
10,000
Final Value
12,376.11
Backtest Period
2025-03-11 to 2026-05-28
1.2 years
Rebalancing
none
Base Currency
EUR
Udate for Sharpe | +19.2% CAGR | ETF Backtest